Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
7.67
-0.55 (-6.69%)
At close: Mar 28, 2025, 4:00 PM
7.73
+0.06 (0.79%)
After-hours: Mar 28, 2025, 4:16 PM EDT
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 619 employees as of December 31, 2024. The number of employees decreased by 90 or -12.69% compared to the previous year.
Employees
619
Change (1Y)
-90
Growth (1Y)
-12.69%
Revenue / Employee
$289,107
Profits / Employee
-$257,661
Market Cap
1.14B
Employees Chart
ADPT News
- 17 days ago - Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma - GlobeNewsWire
- 6 weeks ago - Adaptive Biotechnologies Corporation (ADPT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025 - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025 - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire